Louisiana State University

LSU Digital Commons
Faculty Publications

School of Animal Sciences

8-1-2019

Mitofusin 1 is required for female fertility and to maintain ovarian
follicular reserve
Man Zhang
Yale School of Medicine

Muhammed Burak Bener
Yale School of Medicine

Zongliang Jiang
Yale School of Medicine

Tianren Wang
Yale School of Medicine

Ecem Esencan
Yale School of Medicine

See next page for additional authors

Follow this and additional works at: https://digitalcommons.lsu.edu/animalsciences_pubs

Recommended Citation
Zhang, M., Bener, M., Jiang, Z., Wang, T., Esencan, E., Scott, R., Horvath, T., & Seli, E. (2019). Mitofusin 1 is
required for female fertility and to maintain ovarian follicular reserve. Cell Death and Disease, 10 (8)
https://doi.org/10.1038/s41419-019-1799-3

This Article is brought to you for free and open access by the School of Animal Sciences at LSU Digital Commons.
It has been accepted for inclusion in Faculty Publications by an authorized administrator of LSU Digital Commons.
For more information, please contact ir@lsu.edu.

Authors
Man Zhang, Muhammed Burak Bener, Zongliang Jiang, Tianren Wang, Ecem Esencan, Richard Scott,
Tamas Horvath, and Emre Seli

This article is available at LSU Digital Commons: https://digitalcommons.lsu.edu/animalsciences_pubs/646

Zhang et al. Cell Death and Disease (2019)10:560
https://doi.org/10.1038/s41419-019-1799-3

Cell Death & Disease

ARTICLE

Open Access

Mitofusin 1 is required for female fertility
and to maintain ovarian follicular reserve
Man Zhang1, Muhammed Burak Bener1, Zongliang Jiang
Tamas Horvath1,2 and Emre Seli1

1,3

, Tianren Wang1,4, Ecem Esencan1, Richard Scott III1,

1234567890():,;
1234567890():,;

1234567890():,;
1234567890():,;

Abstract
Mitochondria are dynamic organelles that continually adapt their structure through fusion and ﬁssion in response to
changes in their bioenergetic environment. Targeted deletion of mitochondrial fusion protein mitofusin1 (MFN1) in
oocytes resulted in female infertility associated with failure to achieve oocyte maturation. Oocyte-granulosa cell
communication was impaired, and cadherins and connexins were downregulated, resulting in follicle developmental
arrest at the secondary follicle stage. Deletion of MFN1 in oocytes resulted in mitochondrial dysfunction and altered
mitochondrial dynamics, as well as accumulation of ceramide, which contributed to increased apoptosis and a
reproductive phenotype that was partially rescued by treatment with ceramide synthesis inhibitor myriocin. Absence
of MFN1 and resulting apoptotic cell loss also caused depletion of ovarian follicular reserve, and a phenotype
consistent with accelerated female reproductive aging.

Introduction
Mitochondria have the ability to adapt their shapes
through fusion and ﬁssion (collectively termed mitochondrial dynamics) in response to changes in their
metabolic milieu1. Mitochondrial dynamics are essential
for mitochondrial energy metabolism and stress
response2, and seem to play a key role during oocyte and
pre-implantation embryo development, as mitochondria
become more elongated3, with higher number of cristae
and lower density matrix4.
Fusion is a mechanism that allows one mitochondrion
to compensate for a functional defect in another by
sharing transfer RNAs, ribosomal RNAs, and proteins5,
while ﬁssion may occur when mitochondria are damaged,
accumulate deleterious components, or are subjected to
high levels of cellular stress. Fusion is mediated by
mitofusin 1 (MFN1) and mitofusin 2 (MFN2) in the outer
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mitochondrial membrane and by optic atrophy 1 (OPA1)
in the inner mitochondrial membrane6. A number of
proteins have been implicated in controlling mitochondrial ﬁssion, including dynamin-related protein 1
(DRP1)7.
The fundamental necessity for mitochondrial fusion and
ﬁssion processes in the maintenance of cellular homeostasis has been demonstrated in a number of cell types,
including ﬁbroblasts, epithelial cells, and neurons8–11, and
conﬁrmed by embryonic lethal phenotype of Drp1, Opa1,
Mfn1, and Mfn2 mouse knockout models12–14. Recent
studies also suggest an important role for mitochondrial
dynamics in female reproduction. siRNA-mediated
knockdown of mitochondrial fusion gene Mfn2 in
immature oocytes results in a decline in oocyte maturation15, while oocyte-speciﬁc knockout of mitochondrial
ﬁssion factor Drp1 results in defective follicular maturation and female infertility16.
In this study, we aimed to investigate the role of MFN1
in female fertility and ovarian function. We found that
oocyte-speciﬁc targeted deletion of Mfn1 causes infertility
with defective follicle development and lack of oocyte
maturation. These defects were associated with impaired
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mitochondrial function and dynamics, and accumulation
of ceramide in oocytes; reproductive phenotype could
partially be rescued with ceramide synthesis inhibitor
myriocin. Importantly, in the absence of MFN1, follicular
depletion was accelerated, consistent with a phenotype of
diminished ovarian reserve.

Results

Mfn1 is required for female fertility, oocyte maturation,
and follicle development

Oocyte-speciﬁc Mfn1 knockout (Mfn1−/−) mice were
generated by crossing ﬂoxed Mfn1 mice to transgenic
mice expressing ZP3-Cre17,18, resulting in the loss of Mfn1
mRNA expression in the oocyte, but not in granulosa cells
(Fig. S1A). Mature (8-week-old) Mfn1-deﬁcient female
mice were viable, however, their ovaries were signiﬁcantly
smaller in size (1.65 ± 0.08 vs. 4.8 ± 0.75 μm2, p < 0.05)
and weight (2.017 ± 0.1352 vs. 3.667 ± 0.1856 mg, p < 0.01)
compared to WT (n = 3–6 for each genotype) (Fig. S1B,
S1C and S1D).
To evaluate the fertility of Mfn1−/− mice, we conducted
a continuous mating study using sexually mature female
mice (8-week-old, n = 7 for each genotype) and WT male
mice (12-week-old) of proven fertility. After 12 weeks of
mating, there were no pregnancies or deliveries in
Mfn1−/− mice, while WT female mice produced an
average of 7 pups per mating (0 vs. 6.947 ± 0.429, p <
0.001) (Fig. 1a); both genotypes exhibited normal sexual
behavior (assessed by the presence of a vaginal plug). In
addition,
Mfn1−/− mice failed to produce mature (MII) oocytes (0
vs. 26.67 ± 1.202, p < 0.001) (Fig. 1b).
Assessment of serial ovarian sections revealed that
Mfn1−/− and WT mice ovaries had similar number of
primordial, primary, secondary, and atretic follicles.
However, no antral follicles were found in Mfn1−/−
ovaries (Fig. 1c, e and g). Arrested follicular development
was also observed in the ovaries of Mfn1−/− mice primed
with PMSG (Fig. 1d, f and h).
Mfn1 depletion in oocytes inhibits ovarian secondary
follicle growth

To determine the speciﬁc stage where the secondary
follicle development is blocked in Mfn1−/− mice, we
quantiﬁed type 4 follicles (with two layers of cuboidal
granulosa cells), type 5a follicles (with three layers of
granulosa cells), and type 5b follicles (with many layers of
granulosa cells but no follicle ﬂuid) in Mfn1−/− and WT
mice, as described by Pedersen and Peters19. Mfn1−/−
ovaries showed few type 5b secondary follicles, while they
had signiﬁcantly higher number of type 4 follicles (Fig. 1i
and Fig. S1E). In addition, type 5a and 5b secondary follicles were signiﬁcantly smaller in size in Mfn1−/− ovaries
(Fig. 1j), and there were fewer PCNA-positive
Ofﬁcial journal of the Cell Death Differentiation Association
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(proliferating) granulosa cells in Mfn1−/− mice secondary
follicles compared to WT (30.07% ± 1.135 vs. 68.57% ±
4.88, p < 0.01) (Fig. 1m, n). These data indicate that MFN1
depletion in oocytes blocks the transition of secondary
follicles from two layers to multiple layers of
granulosa cells.
To characterize the factors contributing to abnormal
follicular maturation in Mfn1−/− mice, we assessed the
expression of genes that mediate communication between
oocytes and granulosa cells using qRT-PCR. The expression levels of oocyte-speciﬁc genes Gdf9 and Bmp15,
which regulate follicle development and stimulate granulosa cell proliferation, were signiﬁcantly lower in
Mfn1−/− oocytes (Fig. 1k). Furthermore, the expression
levels of ActivinβB and Follistatin, which are implicated in
the regulation of granulosa cell proliferation and follicle
growth were lower in granulosa cells of Mfn1−/− mice
compared to WT (Fig. 1l), whereas kit-ligand expression,
which promotes oocyte growth, was signiﬁcantly
increased (Fig. 1l). Consistent with granulosa cell dysfunction, serum follicle stimulating hormone (FSH) levels
were higher (25.68 ± 6.19 vs. 7.719 ± 1.59 ng/ml, p < 0.01)
in Mfn1−/− mice compared to WT (Fig. 1o).
Mitochondrial function is impaired in Mfn1−/− oocytes

Next, we assessed mitochondrial function in Mfn1−/−
mice oocytes compared to WT. As Mfn1−/− ovaries were
devoid of antral follicles, secondary follicle-enclosed
oocytes were collected for analysis in both Mfn1−/− and
WT mice. Mfn1−/− oocytes had lower ATP levels (0.61 ±
0.07 vs. 1.45 ± 0.17, p < 0.001) (Fig. 2a), lower expression
of mRNAs coding for electron transport chain (ETC)
complex II (Sdhb), IV (Cox1) and V (Atp5a1) proteins
(Fig. 2c), and higher ROS levels (76.52 ± 3.25 vs. 47.86 ±
3.206 pixel intensity, p < 0.001) (Fig. 2d, e), compared to
WT. These ﬁndings were consistent with mitochondrial
dysfunction in Mfn1−/− oocytes. We also found that
Mfn1−/− oocytes had dramatically lower mtDNA copy
number compared to WT (13,398 ± 870.4 vs. 99,108 ±
15,060, p < 0.001) (Fig. 2b), and decreased expression of
mitochondrial unfolded response (mtUPR) genes Hspe1
and Dnaja3 (Fig. 2f), suggesting a defect in mounting a
stress response. Furthermore, increased mitochondrial
clustering was observed in Mfn1−/− secondary follicleenclosed oocytes compared to the homogeneous distribution of mitochondria in WT (Fig. S8).
Electron microscopy (EM) analysis showed that mitochondria in Mfn1−/− oocytes were larger in size (5.409 ±
0.1975 vs. 4.538 ± 0.1941 μm2, p < 0.001), had increased
mitochondrial coverage area (0.0173 ± 0.0022 vs. 0.0095 ±
0.0021 μm2/ μm2, p < 0.05), and a smaller aspect ratio
(length/width) (1.226 ± 0.015 vs. 1.824 ± 0.081, p < 0.001)
with a more rounded contour (Fig. 2g-j). Additional
abnormalities in the mitochondrial internal structure
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(see ﬁgure on previous page)
Fig. 1 Mfn1−/− mice are infertile, with defective oocyte and follicular maturation. a Fertility of Mfn1−/− and WT female mice (8-week-old) was
assessed by mating with WT males of proven fertility (male/female; 1:2) for 12 weeks. The average number of delivered pups per litter per mouse was
recorded. Data presented as mean ± SEM. N = 7 for each genotype; ***p < 0.001 vs. WT using t-test. b Mfn1−/− and WT female mice (8-week-old)
were superovulated by PMSG and hCG, and the number of mature (MII) oocytes collected from oviducts was counted. Data represent mean ± SEM.
N = 6 for each genotype; ***p < 0.001 vs. WT using t-test. c and d Ovaries from Mfn1−/− and WT mice (8-week-old) primed with PMSG (d) or
unprimed (c) were ﬁxed, embedded, sectioned, and stained with hematoxylin and eosin. Follicle counts using 3 mice ovaries for each genotype were
performed. No antral follicles were found in Mfn1−/− ovaries, with or without PMSG stimulation. e, f, g and h Representative micrographs ovarian
sections from Mfn1−/− and WT mice (8-week-old) with (f and h) or without (e and g) PMSG stimulation. i The number of secondary follicle subtypes
per ovary was quantiﬁed as described in Materials and Methods section (n = 4 mice per genotype). j The diameters of secondary follicle subtypes per
ovary were measured (n = 4 mice per genotype). k Secondary follicle-enclosed oocytes and granulosa cells were collected from Mfn1−/− and WT
ovaries. qRT-PCR was performed to determine Gdf9 and Bmp15 mRNA expression in Mfn1−/− and WT oocytes. l qRT-PCR analysis of ActivinβB,
Follistatin, and kit-ligand in Mfn1−/− and WT granulosa cells was performed. m, n PCNA immunoﬂuorescence assays and the quantiﬁcation of PCNApositive granulosa cells in Mfn1−/− and WT ovaries are shown. o Serum FSH levels in sera of Mfn1−/− and WT mice (n = 7–11 per genotype). Data
presented as mean ± SEM. *p < 0.05, **p < 0.01 vs. WT using t-test. T4: follicles with two layers of cuboidal granulosa cells, T5a: follicles with three
layers of granulosa cells, T5b: follicles with many layers of granulosa cells but no antrum. Data represent mean ± SEM. *p < 0.05 vs. WT using t-test

including decreased number of cristae (0.90 ± 0.15 vs.
2.24 ± 0.36, p < 0.001) and formation of inner membrane
vesicles were also observed in Mfn1−/− oocytes (Fig. 2g,
k). Collectively these data suggest that mitochondrial
function and dynamics are severely impaired in Mfn1−/−
oocytes.
Gene expression is altered in Mfn1−/− oocytes

To identify the genes and pathways affected by absence
of MFN1 in oocytes, we adopted an unbiased approach
with comprehensive genome-wide transcriptomic analysis. Hierarchal clustering of the differentially expressed
genes partitioned into two distinct clusters to separate
Mfn1−/− and WT oocytes (Fig. 3a), suggesting high
reproducibility of the sequencing data. A total of 982
genes were signiﬁcantly differentially expressed (p < 0.05)
in Mfn1−/− oocytes compared to WT, with 654 upregulated and 328 downregulated genes (Fig. 3b). Pathway
analysis of regulated genes indicated signiﬁcant overrepresentation of elements involved in regulation of
adherens junction signaling, death receptor signaling, and
ceramide biosynthesis (Fig. 3c).
Hierarchal clustering of the differentially expressed genes
involved in death receptor signaling partitioned into two
distinct clusters to separate Mfn1−/− and WT oocytes (Fig.
3d). qRT-PCR conﬁrmed increased mRNA expression of
death receptor signaling genes Bad and G2e3 in Mfn1−/−
oocytes compared to WT (Fig. S2A), validating RNAseq
data. Hierarchal clustering of the differentially expressed
genes in adherens junction signaling also partitioned into
two distinct clusters to separate Mfn1−/− and WT oocytes
(Fig. 3e). Differential expression of these genes (Cdh17 and
Myh2) was also conﬁrmed by qRT-PCR (Fig. S2B).
Mfn1 depletion in oocytes results in impaired oocyte and
granulosa cell communication

As we found follicle developmental arrest in Mfn1−/−
mice (Figs. 1 and 2), and RNAseq analysis revealed
Ofﬁcial journal of the Cell Death Differentiation Association

differential expression of adherens junction signaling
genes in Mfn1−/− oocytes, we next assessed the expression of E-cadherin and N-cadherin in WT and Mfn1−/−
oocytes and ovarian sections, by qPCR and immunoﬂuorescence (IF), respectively. E-cadherin is expressed
exclusively in the oocyte and localized to oocyte membrane while N-cadherin is located mainly in granulosa
cells and localizes to the interface between granulosa cells,
as well as granulosa cells and the oocyte20.
IF results showed proper localization and expression of
E-cadherin and N-cadherin in the primary follicles of
Mfn1−/− and WT mice (Fig. 4a, b, e, f). However, levels of
E-cadherin (0.59 ± 0.026 vs. 1 ± 0.124, p < 0.05) and Ncadherin (0.7615 ± 0.019 vs. 1 ± 0.024, p < 0.01) proteins
were signiﬁcantly decreased in the secondary follicles of
Mfn1−/− mice compared to WT (Fig. 4c, d, g, h). Consistent with these data, E-cadherin and N-cadherin mRNA
levels were also decreased in Mfn1−/− oocytes and granulosa cells, respectively (Fig. 4i). In addition, in Mfn1−/−
mice, oocytes were detached from the surrounding
granulosa cells of arrested secondary follicles. Percentage
of normal adhesion between oocyte and granulosa cell
was dramatically lower in Mfn1−/− secondary follicles
compared to WT (27.78% ± 4.005 vs. 95.33% ± 2.028, p <
0.001) (Fig. 4k). Consistent with this ﬁnding, numerous
denuded oocytes were detected following ovarian puncture during GV stage oocyte collection in Mfn1−/− mice
(Fig. S3). These results suggest that Mfn1 depletion in
oocytes inhibits oocyte granulosa cell interactions in
secondary follicles by downregulating the E-cadherin and
N-cadherin expression.
Expression of connexin 37 and connexin 43 is decreased
by Mfn1 deﬁciency

After establishing aberrant expression of E-cadherin
and N-cadherin, we examined whether gap junction formation is also compromised in Mfn1−/− mice. First, we
quantiﬁed connexin37 (Cx37) expression since it is the
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Fig. 2 Mitochondrial function and dynamics are impaired in Mfn1−/− oocytes. a ATP levels were measured in Mfn1−/− and WT female mice (8week-old). b mtDNA copy number was determined by qPCR in individual oocytes collected from Mfn1−/− and WT mice. c Expression of electron
transport chain genes was assessed using qRT-PCR in oocytes collected from Mfn1−/− and WT mice. d ROS levels were measured in Mfn1−/− and WT
oocytes after treatment with H2O2. e Fluorescence intensity of Carboxy-H2DCFDA was used to measure ROS levels. f Expression of mitochondrial
unfolded protein response (mtUPR) genes was assessed using qRT-PCR in oocytes collected from Mfn1−/− and WT mice. g Representative electron
microscopic photographs of oocytes from 8-week-old Mfn1−/− and WT mice ovaries (n = 3 mice assessed in each group). Arrows show
mitochondria. h–k Mitochondrial size (h), aspect ratio (mitochondrial length/ width) (i), coverage area ratio (mitochondrial area/cytoplasm area) (j),
and number of mitochondrial cristae (k), in Mfn1−/− oocytes compared to WT. Data presented as mean ± SEM. *p < 0.05, ***p < 0.001, vs. WT using ttest. ATP adenosine triphosphate, Ndufv1 NADH dehydrogenase (ubiquinone) ﬂavoprotein 1, Sdhb succinate dehydrogenase complex iron sulfur
subunit B, Uqcrc2 ubiquinol cytochrome c reductase core protein 2, Cox1 cytochrome c oxidase subunit I, Atp5a1 ATP synthase, H + transporting,
mitochondrial F1 complex, alpha subunit 1
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similar in the primary follicle-enclosed oocytes (Fig. 4l,
m), but signiﬁcantly decreased in secondary follicleenclosed oocytes of Mfn1−/− mice compared to WT
(0.63 ± 0.048 vs. 1 ± 0.063, p < 0.05) (Fig. 4o, n). Next, we
assessed connexin 43 (Cx43), which is expressed by
granulosa cells and is important in formation of gap
junctions between granulosa cells21. Similarly, while there
was no signiﬁcant difference in Cx43 immunoﬂuorescence in primary follicles (Fig. 4p, q), secondary
follicles showed decreased expression in Mfn1−/− mice
compared to WT (0.70 ± 0.068 vs. 1 ± 0.068, p < 0.05) (Fig.
4s, r). In addition, expression of Cx37 and Cx43 at the
mRNA level were signiﬁcantly decreased in the Mfn1−/−
oocytes and granulosa cells, respectively. (Fig. 4j).
Transzonal processes are impaired in Mfn1−/− follicleenclosed oocytes

Fig. 3 Gene expression is altered in Mfn1−/− oocytes. a Heatmap
illustration showing differentially expressed genes in Mfn1−/− and WT
secondary follicle-enclosed oocytes from 8-week-old mice. The color
spectrum ranging from red to blue indicates normalized levels of
gene expression from high to low. b Volcano plots for RNA-seq
comparing Mfn1−/− and WT oocytes. Red spot represents –log10 (pvalue) ≥2; blue spot represents the –log10 (p-value) <2. c Pathway
enrichment analysis in Mfn1−/− oocytes compared to WT. d, e
Heatmap illustration showing differentially expressed genes involved
in death receptor signaling and adherens junction signaling in Mfn1−/
−
oocytes compared to WT. The color spectrum ranging from red to
blue indicates normalized levels of gene expression from high to low

primary connexin produced by the oocyte and is involved
in forming gap junctions between oocytes and granulosa
cells21. IF results showed that protein levels of Cx37 were
Ofﬁcial journal of the Cell Death Differentiation Association

Transzonal processes (TZPs) anchor the ﬁrst layer of
granulosa cells to the oocyte, enabling the formation of
intercellular gap junctions necessary for follicular development22. Here, we assessed the structure of TZPs by
detecting expression of F-actin. Secondary follicles from
Mfn1−/− and WT mice were ﬁxed and labeled with
rhodamine-phalloidin. WT follicles showed compact and
organized TZPs distributed through the zona pellucida,
however, Mfn1−/− oocytes displayed very weak and disorganized TZPs (Fig. S4A). Linescan proﬁles were used to
measure and quantify TZP density. We calculated the
total ﬂuorescence under the peaks corresponding to the
plasma membrane and zona pellucida (Fig. S4B). In
Mfn1−/− oocytes, the total TZP ﬂuorescence was signiﬁcantly lower compared to WT (1852 ± 159.8 vs.
6807 ± 1004, p < 0.001) (Fig. S4C). EM analysis also
revealed that secondary follicles showed defective contact
between oocyte and granulosa cells (Fig. S4D). Furthermore, gap junctions were signiﬁcantly decreased in the
secondary follicles of Mfn1−/− mice compared to WT
(Fig. S4E, black arrow). Together, these ﬁndings indicated
that oocyte–granulosa cell connections were disrupted in
Mfn1−/− mice.
Mfn1−/− follicle-enclosed oocytes show increased
expression of pro-apoptotic genes

Oocyte apoptosis leads to follicular developmental
arrest23. As the pathway analysis of RNAseq data identiﬁed death receptor signaling genes as being signiﬁcantly
upregulated in Mfn1−/− oocytes, we next assessed the
expression of caspase 6 (CASP6) and cytochrome c
(CYCS), two key mediators of this pathway, in Mfn1−/−
and WT mice. IF results showed signiﬁcantly increased
CASP6 expression in Mfn1−/− oocytes compared to WT
(1.7 ± 0.1072 vs. 1 ± 0.1228, p < 0.05) (Fig. 5a, b). Similarly,
CYCS expression was also elevated in Mfn1−/− mice
oocytes (1.53 ± 0.08 vs. 1 ± 0.15, p < 0.05) (Fig. 5c, b). In
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(see ﬁgure on previous page)
Fig. 4 Deletion of Mfn1 in oocytes inhibits adhesion and gap junction protein expression. a, e E-cadherin and N-cadherin
immunoﬂuorescence in primary follicles of Mfn1−/− and WT mice ovaries. c, h E-cadherin and N-cadherin immunoﬂuorescence in secondary follicles
from Mfn1−/− and WT ovaries. b, d, f, g Quantitative analysis of E-cadherin and N-cadherin immunoﬂuorescence in primary and secondary follicles
from Mfn1−/− and WT mice ovaries. i Secondary follicle-enclosed oocytes and granulosa cells were collected from Mfn1−/− and WT ovaries. Ecadherin and N-cadherin mRNA expression was assessed using qRT-PCR in oocytes and granulosa cells, respectively. j Cx37 and Cx43 mRNA expression
assessed using qRT-PCR in oocytes and granulosa cells, respectively. k Quantiﬁcation of normal adhesion between oocytes and granulosa cells in
secondary follicles of Mfn1−/− and WT mice. Abnormal adhesion was described as low expression of E/N cadherins and increased distance between
the oocyte and granulosa cells. l, p Cx37 and Cx43 immunoﬂuorescence in primary follicles of Mfn1−/− and WT ovaries. o, s Cx37 and Cx43
immunoﬂuorescence in secondary follicles from Mfn1−/− and WT mice ovaries. m, n, q, r Quantitative analysis of Cx37 and Cx43 immunoﬂuorescence
in primary and secondary follicles from Mfn1−/− and WT mice ovaries. Data presented as mean ± SEM. *p < 0.05, **p < 0.01 vs. WT from t-test. PMA
primary follicle, SEC secondary follicle, E-cad E-cadherin, N-cad E-cadherin, Cx37 Connexin37, Cx43 Connexin43

Fig. 5 Oocyte apoptosis and follicular depletion in Mfn1−/− mice. a, c Caspase 6 and cytochrome c immunoﬂuorescence in secondary-follicle
enclosed oocytes from WT and Mfn1−/− mice ovaries. b Quantitative analysis of caspase 6 and cytochrome c immunoﬂuorescence in secondary
follicle-enclosed oocytes from WT and Mfn1−/− mice ovaries. d Secondary follicle-enclosed oocytes were collected from Mfn1−/− and WT ovaries.
Caspase 6 and cytochrome c mRNA expression was assessed by qRT-PCR in oocytes from WT and Mfn1−/− mice. e, g Follicle development was
assessed in ovaries of unstimulated 2 and 6-month-old Mfn1−/− and WT mice. f, h Bar charts showing follicle counts from 4 mice for each genotype
and time point. Data represent mean ± SEM. *p < 0.05, ***p < 0.001 vs. WT using t-test. Cycs cytochrome c, Casp6 caspase 6

addition, abnormal mitochondrial aggregation, which is
considered to be an upstream event to CYCS release
during apoptosis24, was observed in Mfn1−/− oocytes
(Fig. 5c). Consistent with these data, Casp6 and Cycs
mRNA expressions were greatly increased in Mfn1−/−
oocytes (Fig. 5d).
Oocyte speciﬁc deletion of Mfn1 results in accelerated
depletion of ovarian follicular reserve

During ovarian aging, increased apoptosis is observed in
female germ cells25. As we found higher expression of
Ofﬁcial journal of the Cell Death Differentiation Association

pro-apoptotic genes in Mfn1−/− oocytes, and previous
studies have shown accelerated follicle depletion in mice
deﬁcient for mitochondrial stress response gene Clpp26,
we next assessed follicle numbers in unstimulated Mfn1−/
−
and WT mice ovaries at different stages of female
reproductive lifespan. At 2 months, number of primordial,
primary and secondary follicles did not differ between
WT and Mfn1−/− ovaries, while Mfn1−/− ovaries had no
antral follicles (Fig. 5e, f). By 6 months, Mfn1−/− ovaries
had signiﬁcantly lower number of primordial and primary
follicles (Fig. 5g, h). By 9 months, Mfn1−/− ovaries showed
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very low numbers of primordial, primary, and secondary
follicles (Fig. S6A and S6B). At 12 months (Fig. S6D and
S6E), Mfn1−/− ovaries continued to show depletion of
follicles in all stages. Serum Anti-Mullerian hormone
(AMH) levels were also signiﬁcantly lower in 2-, 6-, 9-,
and 12-months-old Mfn1−/− mice compared to WT (Fig.
S6C). These results demonstrate that oocyte-speciﬁc
deletion of Mfn1 results in accelerated follicular depletion, leading to a phenotype similar to that observed in
women with diminished ovarian reserve.
Ceramide is accumulated in Mfn1−/− oocytes and ceramide
inhibitor myriocin partially rescues folliculogenesis in
Mfn1−/− mice

In addition to showing signiﬁcant upregulation of death
receptor signaling, RNAseq analysis revealed increased
ceramide biosynthesis signaling in Mfn1−/− oocytes.
Ceramide has been reported to induce apoptosis by
releasing of cytochrome c from mitochondria and by
activating effector caspases24. By performing IF in ovarian
sections, we found ceramide content of Mfn1−/− oocytes
to be signiﬁcantly higher compared to WT (3.56 ± 0.09 vs.
1 ± 0.03, p < 0.001) (Fig. 6a, b). In addition, Cer4 and
Smpd2 (enzymes required for ceramide synthesis)
were upregulated in Mfn1−/− oocytes compared to WT
(Fig. S7).
We then tested whether ceramide synthesis inhibitor
myriocin could rescue Mfn1−/− oocyte function and follicle growth. Mfn1−/− mice were injected with myriocin
(1.5 mg/kg) daily for 21 consecutive days before harvesting ovaries, and compared to Mfn1−/− mice injected with
saline, and WT mice injected with saline. IF results
showed signiﬁcantly lower ceramide levels in oocytes of
Mfn1−/− mice treated with myriocin compared with
untreated Mfn1−/− mice (Fig. 6c, d). Ovaries of Mfn1−/−
mice treated with myriocin were heavier (Fig. 6e), and
showed a higher number of PCNA-positive granulosa
cells in secondary follicles (52.21% ± 1.85 vs. 17.01% ±
3.87, p < 0.01) (Fig. 6f, g). In addition, ovaries of Mfn1−/−
mice treated with myriocin had an increased number of
follicles with more than two layers of granulosa cells (type
5a and 5b) compared to untreated Mfn1−/− mice ovaries
(Fig. 6h, i). Most importantly, Mfn1−/− mice treated with
myriocin developed antral follicles (Fig. 6h). Collectively,
our ﬁndings indicate that inhibition of ceramide synthesis
using myriocin partially rescues impaired follicle development in Mfn1−/− mice.

Discussion
Mitochondria play an essential role in generating energy
to support oocyte and embryo development27. In addition,
they have a number of additional functions including
regulation of calcium metabolism, signal transduction,
and apoptosis28, with yet undeﬁned implications for early
Ofﬁcial journal of the Cell Death Differentiation Association
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development. In the current study, we aimed to investigate whether oocyte-speciﬁc targeted deletion of Mfn1, a
key regulator of mitochondrial fusion, affects female fertility. Mfn1−/− mice did not produce any pups (Fig. 1a)
and did not generate mature oocytes (Fig. 1b). The
communication between Mfn1−/− oocytes and surrounding granulosa cells through paracrine factors and
cell junctions were impaired (Figs. 1k, l, 4) and follicles of
Mfn1−/− mice arrested at the pre-antral stage (Fig. 1c-j).
Collectively, these ﬁndings demonstrate that folliculogenesis and oogenesis require MFN1 in oocytes, and that
MFN2, the other mammalian mitofusin with approximately 60% sequence homology to MFN1 (and similar Nterminal GTPase domain including canonical G1–G4
motifs), cannot compensate for the absence of MFN129.
During the past two decades, sphingolipids have
emerged as essential second messengers in a variety of
signal transduction pathways30. Most of this research has
focused on ceramide, a membrane sphingolipid and an
important inducer of programmed cell death24,25,30, and
cell cycle arrest31–33. Previous studies showed that ceramide accumulation in porcine oocytes induced by palmitic acid is associated with mitochondrial dysfunction34,
and that acid ceramidase (a ceramide metabolizing
enzyme), improves the quality of oocytes and embryos
and the outcome of IVF35. Interestingly, ceramide has
been implicated in age-related acceleration of apoptosis in
the female germline25,36. Based on these data and the
RNAseq analyses, which identiﬁed ceramide biosynthesis
pathway as a key target affected by Mfn1 deletion, we
tested whether elevated ceramide levels contribute to the
Mfn1−/− reproductive phenotype by inducing apoptosis
and promoting cell cycle arrest. We found ceramide
expression in Mfn1−/− oocytes to be dramatically
increased compared to WT. In addition, treatment of
Mfn1−/− mice with myriocin, which blocks de novo ceramide synthesis by inhibiting the key enzyme serine palmitoyltransferase37–39, resulted in improved growth of
secondary follicles and formation of antral follicles, partially rescuing the reproductive phenotype. Our ﬁndings
suggest that drugs targeting down-stream metabolic by
products, such as ceramide, can potentially treat impaired
oocyte viability in the setting of metabolic dysfunction.
The number of resting follicles available in the ovary
constitutes the ovarian reserve, and is the primary
determinant of response to the ovarian stimulation in
women undergoing infertility treatment40. In addition,
ovarian reserve is a key determinant of age at menopause.
Recently, global germline deletion of Clpp, which regulates mtUPR, was found to cause accelerated follicular
depletion26. In the current study, we observed a depletion
of primordial and primary follicles starting at 6 months,
and depletion of all follicular stages at 9 and 12 months,
consistent with an accelerated reproductive aging
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Fig. 6 Ceramide accumulation and rescue in Mfn1−/− mice. a, b Ceramide immunoﬂuorescence in secondary follicle-enclosed oocytes from
Mfn1−/− and WT ovarian sections. Bar chart shows the quantitative analysis of ceramide intensity in Mfn1−/− and WT ovarian sections. c, d Mfn1−/−
and WT mice (8-week-old) were injected with myriocin 1.5 mg/kg (Mfn1−/− + myriocin) once a day for 21 consecutive days, and compared to
Mfn1−/− or WT controls injected with saline. Ovaries were extracted and ceramide immunoﬂuorescence in secondary follicle-enclosed oocytes was
assessed. Bar chart shows the quantitative analysis of ceramide intensity. e Ovary weight in WT, Mfn1−/− and myriocin-treated Mfn1−/− (Mfn1−/−
+
myriocin) mice. f, g PCNA immunoﬂuorescence assays and the quantiﬁcation of PCNA-positive granulosa cells in WT, Mfn1−/−, and Mfn1−/− +
myriocin mice ovarian sections. h, i Representative ovarian section micrographs of WT, Mfn1−/−, and Mfn1−/− + myriocin mice. The percentage of
secondary follicle subtypes per ovary was quantiﬁed (n = 5–8 mice per group). Data presented as mean ± SEM. *p < 0.05 vs. WT using t-test. T4:
follicles with two layers of cuboidal granulosa cells, T5a: follicles with 3 layers of granulosa cells, T5b: follicles with many layers of granulosa cells but
no antral cavity

phenotype in Mfn1−/− mice. Mitochondrial dysfunction
has been reported to accelerate aging by causing increased
ROS levels41, accumulation of mtDNA mutations42,
defective ETC function43, altered mitochondrial
Ofﬁcial journal of the Cell Death Differentiation Association

metabolism44 and lower mitochondrial membrane
potential45. In addition, targeted deletion of PolgA
(mtDNA polymerase) causes increased mtDNA mutations and a premature aging phenotype46. Our
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Fig. 7 A putative model on the role of MFN1 in female reproductive function. Mitochondrial fusion protein MFN1 is required for female fertility
and oocyte and follicle development. In the absence of MFN1, oocytes show mitochondrial dysfunction and accumulation of ceramide, leading to
impaired oocyte-granulosa cell communication, increased apoptosis, and accelerated follicular depletion

observations constitute a novel paradigm connecting
impaired mitochondrial dynamics with accelerated follicular depletion and diminished ovarian reserve.
Depletion of primordial follicles in Mfn1−/− mice is
likely due to accelerated recruitment rather than atresia,
as Zp3-mediated targeted deletion occurs only after follicles start growing (at the primary follicle stage)37–39.
AMH, a hormone produced by the granulosa cells of
preantral and small antral follicles, beginning when primordial follicles start developing into primary follicles47,48, plays a key role in limiting follicle recruitment.
Small antral follicles are likely the primary source of AMH
due to the larger numbers of granulosa cells they contain
and their more developed microvasculature48. As
Mfn1−/− mice have smaller secondary follicles with a
lower number of granulosa cells, and do not form antral
follicles, it is not surprising that their AMH levels were
lower compared to WT as early as 2 months of age (Fig.
S6), possibly contributing to accelerated follicle
recruitment.
In this study, we have three important and potentially
related ﬁndings regarding MFN1′s role on female reproduction. First, we uncovered that oocyte speciﬁc deletion
of Mfn1 results in female infertility due to defective oocyte
Ofﬁcial journal of the Cell Death Differentiation Association

maturation and follicular development. Second, we
observed that targeted deletion of Mfn1 in oocyte results
in disruption of adherens and gap junctions between
oocytes and granulosa cells and increased apoptosis
caused at least in part by accumulation of ceramide.
Third, we observed that targeted deletion of Mfn1 in
oocytes results in accelerated follicular depletion, which
represents a phenotype reminiscent of diminished ovarian
reserve and premature ovarian aging (Fig. 7).

Methods
Animals

All animal care and experimental procedures were
conducted in accordance with Yale University animal
research requirements, using protocols approved by the
Institutional Animal Care and Use Committee (protocol #
2017–11207). Mfn1ﬂox/ﬂox mice were purchased from The
Jackson Laboratory (stock number 026401). Zp3-Cre
mice17,18 (where Cre is driven by Zp3 promoter) in
C57BL/6 background were also obtained from The Jackson Laboratory (stock number 003651). Mfn1ﬂox/ﬂox mice
were crossbred with Zp3-Cre mice to produce mice with
oocyte-speciﬁc Mfn1 deletion (Mfn1ﬂ/ﬂ/Zp3-Cre mice),
and for simplicity, they are referred to as Mfn1−/− mice.
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Female Mfn1−/− mice and wild-type (WT) littermates
were used in experiments. Genotyping was carried out
using the primers shown in Table S1.
Assessment of fertility

To evaluate the fertility of Mfn1−/− female mice, seven
female mice from each group (Mfn1−/− or WT, 8-weekold) were mated with adult (12-week-old) WT males of
proven fertility for 12 weeks. Two female mice were
housed with one adult male mouse, and male mice were
rotated weekly. Mating cages were monitored daily, and
the number of litters and pups were recorded.
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germinal vesicle (GV) stage oocytes, ovaries were obtained
from 8-week-old Mfn1−/− and WT mice51 44–48 h after
intraperitoneal injection of 5 IU PMSG (Sigma, St. Louis,
MO). Ovaries were then punctured with a 26-gauge
needle, and GV stage oocytes were collected in M2
medium (Sigma, St. Louis, MO) and 10 μM milrinone
(Sigma, St. Louis, MO) to prevent meiotic resumption. To
obtain mature oocytes, an additional injection of 5 IU of
human chorionic gonadotrophin (hCG; Sigma, St. Louis,
MO) to induce oocyte maturation and ovulation was
given 48 h after the PMSG injection. Unfertilized oocytes
at metaphase of the second meiotic division (MII) were
collected from oviducts 14 h after the hCG injection.

Histomorphometric analysis of folliculogenesis in ovaries

For hematoxylin and eosin (H&E) staining, ovaries from
8-week-old Mfn1−/− and WT mice primed (or not
primed) with pregnant mare serum gonadotropin (PMSG)
48-h before collection, were ﬁxed in 4% (w/v) paraformaldehyde in Dulbecco’s phosphate buffered saline
(DPBS; Sigma) at room temperature overnight, and stored
at 4 °C in fresh 70% ethanol until processed. Ovaries were
then dehydrated, embedded in parafﬁn, and 5 μm serial
sections were stained with H&E using standard protocol49. Every ﬁfth section was assessed, and the total
number of follicles for each ovary was determined by
counting the follicles containing oocytes with a visible
nucleus. Primordial, primary, secondary, and antral follicles were classiﬁed as described previously50. Brieﬂy, primordial follicles were deﬁned as an oocyte surrounded by
a single layer of squamous granulosa cells. Primary follicles possessed an oocyte surrounded by a single layer of
cuboidal granulosa cell layer. Secondary follicles consisted
of an oocyte surrounded by two or more layers of cuboidal
granulosa cells with no visible antrum. Antral follicles
contained four or more layers of granulosa cells with a
clearly deﬁned single antral space. Secondary follicles
were further categorized into type 4 follicles (with two
layers of cuboidal granulosa cells), type 5a follicles (with 3
layers of granulosa cells) and type 5b follicles (with many
layers of granulosa cells but no follicle ﬂuid), as described
by Pedersen and Peters19. The diameters of sub-grouped
secondary follicles per ovary were measured using ImageJ
software (National Institute of Health, NIH, Bethesda,
MD, USA).
Follicle and oocyte collection

Secondary follicles were collected from 8-week-old
Mfn1−/− and WT mice by digesting the ovaries with
1.5 mg/mL collagenase type V (Sigma, St. Louis, MO) for
1 h at 37 °C in M2 medium (Sigma, St. Louis, MO)5.
Secondary follicle-enclosed oocytes (referred as the
oocytes) and granulosa cells were collected by further
digesting the harvested secondary follicle with Accutase
solution (Sigma, St. Louis, MO) for 15 min. To collect
Ofﬁcial journal of the Cell Death Differentiation Association

Electron microscopic analysis

For transmission electron microscopy, 3 Mfn1−/− and 3
WT female mice were deeply anesthetized 44 h after
PMSG injection and perfused with 4% paraformaldehyde/
PBS. Both ovaries were removed and ﬁxed overnight at
4 °C with the ﬁxative solution (paraformaldehyde 2%,
glutaraldehyde 2.5% in cacodylate buffer 0.1 M, pH 7.4).
After ovaries were rinsed in the same buffer twice, they
were postﬁxed in 1% OsO4 in 0.1 M cacodylate buffer at
room temperature for 60 min. Specimens were stained en
bloc with 2% aqueous uranyl acetate for 30 min, dehydrated in a graded series of ethanol to 100% and
embedded in Poly/bed 812 resin. Blocks were polymerized
in a 60 °C oven for 24 h. Thin sections (60 nm) were cut by
a Leica ultramicrotome and post-stained with 2% uranyl
acetate and lead citrate. Cell sections were examined with
a FEI Tecnai transmission electron microscope and digital
images were recorded with an Olympus Morada CCD
camera and iTEM imaging software. Follicle-enclosed
oocytes were imaged at ×11500 magniﬁcation. Images
were taken covering the entire follicle. ImageJ software
was used to analyze the mitochondria morphology.
Mitochondria area, cytoplasmic area, total mitochondria
number, number of cristae, mitochondria length and
width were measured. Mitochondrial coverage area was
calculated by dividing the total area of mitochondria to
the total area of the cytoplasm.
Quantiﬁcation of mtDNA copy number in oocytes

To quantify mtDNA levels in oocytes, Cox3 fragment
was ampliﬁed using the primers shown in Table S1 and
subcloned into pCR™2.1-TOPO®—cloning vector (Invitrogen, Carlsbad, CA) as previously described16. One Shot
TOP10 Chemically Competent E. coli were transformed
and grown overnight at 37 °C. Recombinant plasmids
were puriﬁed using Qiagen plasmid isolation kit and the
inserted mtDNA fragment was conﬁrmed by DNA
sequence analysis. Plasmid DNA was quantiﬁed using
NanoDrop 2000 spectrophotometer (Thermo Scientiﬁc,
Waltham, MA). A standard curve from 108 to 101 plasmid
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molecules was generated by serial 10-fold dilutions. Single
oocytes from Mfn1−/− and WT mice were individually
lysed in 10 μl lysis solution containing 125 μg/ml Proteinase K and 17 μM SDS in sterile water by incubating at
55 °C for 2 h. Then, proteinase K was inactivated by
heating the lysis mix at 95 °C for 10 min and the mix was
used directly for downstream PCR. Reactions were performed in triplicates. Each 10 μl reaction contained 5 μl of
SYBR Green supermix (Bio-Rad Laboratories, Hercules,
CA), approximately 0.3 μM of each primer, and 1/3 of
oocyte’s total DNA. Each individual oocyte’s mtDNA copy
number was extrapolated from the standard curve.
Determination of ROS levels

6-carboxy-2′,7′-dichlorodihydroﬂuorescein
diacetate
(carboxy-H2DCFDA) (Life Technologies, Carlsbad, CA)
was used to assess reactive oxygen species (ROS) levels in
mouse follicle-enclosed oocytes. This nonﬂuorescent
chemical passes through the plasma membrane and converts to green ﬂuorescent form upon oxidation with ROS
and it stays inside the cell for a prolonged period because
of its negative charges52. We induced ROS generation by
exposing follicle enclosed oocytes to 20 mM H2O2 for
5 min and then incubated these oocytes with 30 µM
H2DCFDA in M2 medium for 20 min. Oocytes were
washed three times in H2DCFDA-free media and images
were captured using Leica SP5 confocal microscope.
ImageJ software was used to quantify the ﬂuorescence.
Quantiﬁcation of ATP

ATP content of individual single oocytes was determined using the ATP bioluminescent somatic cell assay
kit (Sigma, St. Louis, MO). Single oocytes were collected,
lysed, and stored individually in 100 μl of somatic cell
ATP releasing reagent at −80 °C before use. 100 μl ATP
Assay Mix Working Solution was added individually to
96-well plate wells and kept at room temperature for
3–5 min. To a separate vial containing 100 μl of 1× icecold somatic cell ATP releasing reagent, 50 μl of samples
to be assayed (or standards) were added and swirled
briskly; 100 μl of this mix was then transferred individually to the 96-well plate containing 100 μl of ATP Assay
Mix Working Solution, and the amount of light emitted
was measured immediately with Dynex MLX microliter
plate luminometer (Dynex Technologies, Chantilly, VA).
Background luminescence was subtracted from all readings. ATP in single oocyte samples was calculated by
comparison to a standard curve generated over the range
2.5–500 fmol/100 μl.
Quantitative reverse-transcription polymerase chain
reaction (qRT-PCR)

Total RNA was obtained from follicle-enclosed oocytes
and the granulosa cells using RNAqueous Microkit
Ofﬁcial journal of the Cell Death Differentiation Association
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(Thermo Fisher Scientiﬁc, Waltham, MA). Reverse transcription was performed using the RETROscript kit
(Thermo Fisher Scientiﬁc) in two steps: ﬁrst, template
RNA and random primers were incubated at 85 °C for
3 min to eliminate any secondary structures, and then the
buffer and enzyme were added and the reaction was
carried out at 42 °C for 1 h. qRT-PCR was carried out in
an iCycler (Bio-Rad Laboratories, Hercules, CA). cDNA
was prepared as described above, and assayed in triplicates. Each experiment was repeated at least three times
using individual animals from each genotype. Each 10-µl
reaction contained 5 µl of SYBR Green Supermix (Bio-Rad
Laboratories), 3 µl of H2O, 0.5 µl of each primer, and 1 µl
of cDNA. TaqMan Gene expression assays (Life Technologies, Carlsbad, CA) were also used following manufacturer’s instructions. Brieﬂy, each 20-µl reaction
contained 1 µl of 20× TaqMan gene expression assay,
10 µl of 2× TaqMan Gene expression master mix, 4 µl of
cDNA template, and 5 µl of H2O. The 2−ΔΔCT (cycle
threshold) method was used to calculate relative expression levels after normalization to β-actin levels. The primers used for real-time PCR reactions were included in
Table S1.
Staining of transzonal processes

Secondary follicles were ﬁxed in 4% formaldehyde
(Sigma, St. Louis, MO) for 1 h at 37 °C, washed in phosphate buffered saline (PBS) with 0.1% TritonX-100 and
0.01% polyvinyl alcohol (PVA), and blocked with 3% BSA
for 30 min at room temperature. F-actin transzonal processes (TZPs) were labeled using rhodamine-phalloidin
(Life Technologies, Carlsbad, CA). After staining, the
follicles were washed three times in PBS/PVA and
observed with a Leica SP5 spectral scanning confocal
microscope. Image J software was used to quantify the
data by using the plot proﬁle tool. A line was drawn
through the entire follicle to get a line-scan proﬁle. The
peaks in the proﬁle corresponding the zona pellucida and
plasma membrane were used for quantiﬁcation of the
total ﬂuorescence value.
Immunoﬂuorescence staining

Parafﬁn embedded tissue sections were used for staining. For deparafﬁnization, slides were heated for 45 min at
65 °C prior to rehydration step. In the rehydration step,
slides were treated three times with 100% xylene and three
times with 100% ethanol. For antigen retrieval, rehydrated
slides were incubated with citrate buffer (pH 6.0) in a
pressure cooker for 1 h. After cooling down to 27 °C,
tissues were permeabilized in 0.5% Triton X-100 for
10 min. This step was followed by a blocking step, where
slides were incubated in BSA for 45 min, then washed in
0.5% BSA diluted in PBS (PBB), three times. Then, slides
were incubated overnight at 4 °C with primary antibodies
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for PCNA, E-cadherin, N-cadherin, connexin 37, connexin 43, cytochrome c, caspase 6 (Santa Cruz Biotechnology, Dallas, TX) or ceramide (Enzo Life Sciences,
Farmingdale, NY) diluted 1:50. The following day, slides
were washed three times with PBB and incubated for
60 min at room temperature with Alexa ﬂuor 594conjugated or Alexa ﬂuor 488-conjugated secondary
antibodies (Thermo Fisher Scientiﬁc, Waltham, MA)
diluted 1:200. Slides were then washed three times in PBS,
incubated with 4′, 6-diamidino-2-phenylindole (DAPI;
1:1000) (Life Technologies, Carlsbad, CA), and washed in
PBS. Slides were stored at 4 °C until imaging.
FSH and AMH testing

To determine serum follicle stimulating hormone
(FSH) and Anti-Mullerian hormone (AMH) levels, samples were sent to University of Virginia Center for
Research in Reproduction Ligand Assay and Analysis
Core, where an in-house RIA (radioimmunoassay) was
used to measure FSH, ANSH ELISA kit was used to
measure AMH levels.
RNA sequencing and data analysis

Five secondary follicle enclosed oocytes collected from
Mfn1−/− or WT mice (n = 3) were pooled and cDNA was
ampliﬁed using Smart-Seq2 protocol as previously
described53,54. Brieﬂy, poly(A) RNAs were reversetranscribed directly in whole cell lysate in 0.2% Triton
X-100 and 2 U/ul of RNase inhibitors (Invitrogen) in
RNase free water. cDNA was then ampliﬁed and measured by Qubit 3.0 (Life Technologies, Carlsbad, CA) for
concentration and Tapestation 4200 (Agilent Technologies, Santa Clara, CA) for size distribution. RNA
sequencing libraries were constructed using Nextera® XT
DNA Library Preparation Kit (Illumina, San Diego, CA)
and multiplexed using Nextera® XT Index Kit (Illumina).
Libraries were quantiﬁed by Qubit and Tapestation 4200.
Indexed libraries were then pooled and sequenced on
Illumina’s Hiseq 2500 platform with 75 bp pair-end reads.
In total, we analyzed 6 samples and obtained approximately 212 million reads. The raw FASTQ ﬁles and
normalized read counts are available at Gene Expression
Omnibus (GEO) (www.ncbi.nlm.nih.gov/geo) under the
accession number (GSE125699).
Multiplexed sequencing reads that passed ﬁlters were
trimmed to remove adapters using Cutadapt and lowquality reads were pre-ﬁltered by FASTX-Toolkit before
mapping. Clean reads were aligned to the mouse genome
(GRCm38/mm10) using STAR with default parameters.
Individual mapped reads were quantiﬁed to annotation
model to calculate gene counts. Differentially expression
analysis between Mfn1−/− or WT groups was performed
using DESeq 2 package. Differentially expressed genes
between Mfn1−/− and WT groups were determined using
Ofﬁcial journal of the Cell Death Differentiation Association
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false discovery rate (FDR) of p value <0.05, foldchange >2
and a minimal of 5 reads as cutoffs. Expression pattern
clusters were generated by the K-means clustering algorithm using R. DAVID and Ingenuity Pathway Analysis
(IPA) software were used to perform Gene Ontology (GO)
and pathways analyses, respectively.
Myriocin rescue treatment

Mfn1−/− or WT mice were intraperitoneally injected
with Myriocin 1.5 mg/kg (Sigma, St. Louis, MO) or saline
once a day for 21 days prior to experiments. Ovaries were
then extracted to assess follicular development and
junction protein expression through H&E and immunoﬂuorescence staining, respectively.
Statistical analysis

Quantitative data are expressed as mean ± SEM. Student’s t-test was used to analyze the statistical signiﬁcance
between two groups. Data are representative of at least
three independent experiments unless otherwise speciﬁed. All statistical analyses were done using Graph Pad
Prism software version 7 and signiﬁcance was assessed at
p < 0.05.
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